Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Martin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Plos One|September 30, 2014
Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequencesBenjamas Aiamkitsumrit, Will Dampier, Julio Martin-Garcia, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaignRosario Diaz, Sandra A Luengo-Arratta, João D Seixas, et al.
Journal of Computer Assisted Tomography|June 17, 2006
Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trialJuha Halavaara, Josy Breuer, Carmen Ayuso, et al.
Bioorganic & Medicinal Chemistry|March 12, 2016
Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruziLívia Bandeira Costa, Marcos Veríssimo de Oliveira Cardoso, Gevanio Bezerra de Oliveira Filho, et al.
Biochemical Pharmacology|August 12, 2009
Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptorEdgar R Wood, Lisa Shewchuk, Anne Hassel, et al.
Mbio|January 11, 2022
Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial CompoundAya Hefnawy, Gabriel Negreira, Marlene Jara, et al.
Journal of Biomolecular Screening|February 17, 2012
Lead discovery for microsomal prostaglandin E synthase using a combination of high-throughput fluorescent-based assays and RapidFire mass spectrometryMelanie V Leveridge, Ana Isabel Bardera, William LaMarr, et al.
Scientific Reports|March 6, 2015
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resourceImanol Peña, M Pilar Manzano, Juan Cantizani, et al.
ACS Infectious Diseases|January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
The Journal of Biological Chemistry|May 1, 2004
Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activityAngus Cameron, Jon Read, Rebecca Tranter, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Plos One|September 30, 2014
Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequencesBenjamas Aiamkitsumrit, Will Dampier, Julio Martin-Garcia, et al.
Plos Neglected Tropical Diseases|October 24, 2014
Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaignRosario Diaz, Sandra A Luengo-Arratta, João D Seixas, et al.
Journal of Computer Assisted Tomography|June 17, 2006
Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trialJuha Halavaara, Josy Breuer, Carmen Ayuso, et al.
Bioorganic & Medicinal Chemistry|March 12, 2016
Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruziLívia Bandeira Costa, Marcos Veríssimo de Oliveira Cardoso, Gevanio Bezerra de Oliveira Filho, et al.
Biochemical Pharmacology|August 12, 2009
Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptorEdgar R Wood, Lisa Shewchuk, Anne Hassel, et al.
Mbio|January 11, 2022
Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial CompoundAya Hefnawy, Gabriel Negreira, Marlene Jara, et al.
Journal of Biomolecular Screening|February 17, 2012
Lead discovery for microsomal prostaglandin E synthase using a combination of high-throughput fluorescent-based assays and RapidFire mass spectrometryMelanie V Leveridge, Ana Isabel Bardera, William LaMarr, et al.
Scientific Reports|March 6, 2015
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resourceImanol Peña, M Pilar Manzano, Juan Cantizani, et al.
ACS Infectious Diseases|January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
The Journal of Biological Chemistry|May 1, 2004
Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activityAngus Cameron, Jon Read, Rebecca Tranter, et al.
Pageof 5